When Ugly Facts SLAY A Good Theory!

**Low-dose aspirin linked to bleeding in the skull, new report says…

     Taking low-dose aspirin to prevent heart disease and stroke is associated with an increased risk of bleeding in the skull in people without a history of those conditions, according to a new report.

Researchers analyzed data from 13 previous studies in which over 130,000 people ages 42 to 74, who didn’t have a history of heart disease or stroke, were given either low-dose aspirin or a placebo for the prevention of these conditions. An aspirin is typically defined as low-dose if it is between 75 and 100 milligrams, but most over-the-counter pills are around 81 milligrams.

 

**People who took the placebo had a 0.46% risk of having a head bleed during the combined trial periods. For those who took low-dose aspirin, the risk was 0.63%, the equivalent of an additional 2 out of every 1,000 people developing a bleed, according to the study, published Monday in the journal JAMA Neurology. People from Asian backgrounds and those with a body mass index under 25 had the highest risk.

 

With daily low-dose aspirin use, risks outweigh benefits for older adults

 

Three recent large studies concluded that taking a daily low-dose aspirin is, at best, a waste of money for healthy older adults. At worst, it may raise their risk of internal bleeding and early death. In light of this evidence, aspirin is no longer recommended as a preventive measure for older adults who don’t have a high risk of or existing heart disease, according to guidelinesannounced in March by the American College of Cardiology and the American Heart Association.

 

Daily aspirin to prevent heart attacks no longer recommended for older adults

“Clinicians should be very selective in prescribing aspirin for people without known cardiovascular disease,” Johns Hopkins cardiologist Dr. Roger Blumenthal, who co-chaired the March guidelines, said in a statement. “It’s much more important to optimize lifestyle habits and control blood pressure and cholesterol as opposed to recommending aspirin.

 

Because head bleeds are often catastrophic and the benefits of low-dose aspirin are not well-established, doctors should use caution when prescribing this medication to people without symptomatic cardiovascular disease, the study’s authors said.

 

**Mark your calendar for the next Elevation Health Blockbuster Workshop: Diabetes and Blood Sugar Control, Monday, June 17th, 2019, @ The Lake Mary Events Center!

 

Source: https://www.cnn.com/2019/05/13/health/aspirin-head-bleed-study/index.html